T.R. Auton

3.9k total citations · 2 hit papers
27 papers, 3.0k citations indexed

About

T.R. Auton is a scholar working on Molecular Biology, Pharmaceutical Science and Computational Theory and Mathematics. According to data from OpenAlex, T.R. Auton has authored 27 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Pharmaceutical Science and 4 papers in Computational Theory and Mathematics. Recurrent topics in T.R. Auton's work include Advancements in Transdermal Drug Delivery (6 papers), Computational Drug Discovery Methods (4 papers) and Receptor Mechanisms and Signaling (4 papers). T.R. Auton is often cited by papers focused on Advancements in Transdermal Drug Delivery (6 papers), Computational Drug Discovery Methods (4 papers) and Receptor Mechanisms and Signaling (4 papers). T.R. Auton collaborates with scholars based in United Kingdom, Germany and Australia. T.R. Auton's co-authors include Christopher W. Murray, Matthew Eldridge, Gaia V. Paolini, M. Prudhomme, J. C. R. Hunt, James F. Glover, Lewis L. Smith, Edward A. Lock, Martin K. Ellis and W. McLean Provan and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Fluid Mechanics and Cancer Research.

In The Last Decade

T.R. Auton

27 papers receiving 2.9k citations

Hit Papers

Empirical scoring functions: I. The development of a fast... 1987 2026 2000 2013 1997 1987 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T.R. Auton United Kingdom 16 1.3k 914 655 485 441 27 3.0k
Takeshi Kinoshita Japan 38 2.1k 1.6× 52 0.1× 316 0.5× 376 0.8× 273 0.6× 354 5.9k
Jean‐Loup Faulon France 44 3.0k 2.3× 1.1k 1.3× 27 0.0× 156 0.3× 792 1.8× 124 4.6k
Jinan Wang China 36 4.1k 3.1× 1.5k 1.7× 38 0.1× 228 0.5× 89 0.2× 160 7.7k
E. N. Lightfoot United States 36 1.3k 1.0× 54 0.1× 908 1.4× 152 0.3× 2.2k 4.9× 169 4.9k
Mi‐Kyung Lee South Korea 24 2.5k 1.9× 426 0.5× 75 0.1× 50 0.1× 301 0.7× 75 3.6k
Michael Weiß Germany 26 505 0.4× 93 0.1× 204 0.3× 30 0.1× 265 0.6× 129 2.8k
David Touboul France 48 2.8k 2.1× 188 0.2× 1.3k 2.0× 15 0.0× 603 1.4× 259 8.5k
Staffan Folestad Sweden 38 453 0.3× 51 0.1× 469 0.7× 117 0.2× 987 2.2× 112 3.2k
Shuo Huang China 32 1.2k 0.9× 69 0.1× 358 0.5× 138 0.3× 1.5k 3.5× 130 2.9k
Mitsuru Tanaka Japan 35 1.4k 1.0× 20 0.0× 161 0.2× 175 0.4× 551 1.2× 255 4.9k

Countries citing papers authored by T.R. Auton

Since Specialization
Citations

This map shows the geographic impact of T.R. Auton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T.R. Auton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T.R. Auton more than expected).

Fields of papers citing papers by T.R. Auton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T.R. Auton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T.R. Auton. The network helps show where T.R. Auton may publish in the future.

Co-authorship network of co-authors of T.R. Auton

This figure shows the co-authorship network connecting the top 25 collaborators of T.R. Auton. A scholar is included among the top collaborators of T.R. Auton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T.R. Auton. T.R. Auton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Auton, T.R., et al.. (2007). In vitro demonstration that pemetrexed is a good substrate for glucarpidase. Cancer Research. 67. 4773–4773. 2 indexed citations
2.
Schwartz, Stefan, Klaus Borner, Peter Martus, et al.. (2007). Glucarpidase (Carboxypeptidase G2) Intervention in Adult and Elderly Cancer Patients with Renal Dysfunction and Delayed Methotrexate Elimination After High-Dose Methotrexate Therapy. The Oncologist. 12(11). 1299–1308. 69 indexed citations
3.
Auton, T.R., et al.. (2005). Edge sharpness as a function of depth in plain film radiography. 52(3). 13–16. 1 indexed citations
4.
Brown, Matthew A., et al.. (2004). Randomized double-blind placebo-controlled study of an angiotensin immunotherapeutic vaccine (PMD3117) in hypertensive subjects. Clinical Science. 107(2). 167–173. 83 indexed citations
5.
Auton, T.R., Harvey L. Sharp, Lars Sjöström, et al.. (2003). Evaluation of two carrier protein–angiotensin I conjugate vaccines to assess their future potential to control high blood pressure (hypertension) in man. British Journal of Clinical Pharmacology. 56(5). 505–512. 41 indexed citations
6.
Gardiner, Sheila M., T.R. Auton, Harvey L. Sharp, et al.. (2000). Active immunization with angiotensin I peptide analogue vaccines selectively reduces the pressor effects of exogenous angiotensin I in conscious rats. British Journal of Pharmacology. 129(6). 1178–1182. 39 indexed citations
7.
Murray, Christopher W., T.R. Auton, & Matthew Eldridge. (1998). Empirical scoring functions. II. The testing of an empirical scoring function for the prediction of ligand-receptor binding affinities and the use of Bayesian regression to improve the quality of the model. Journal of Computer-Aided Molecular Design. 12(5). 503–519. 101 indexed citations
8.
Eldridge, Matthew, et al.. (1997). Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes. Journal of Computer-Aided Molecular Design. 11(5). 425–445. 1401 indexed citations breakdown →
9.
Purchase, I. F. H. & T.R. Auton. (1995). Thresholds in Chemical Carcinogenesis. Regulatory Toxicology and Pharmacology. 22(3). 199–205. 29 indexed citations
10.
Auton, T.R., Philip A. Botham, & Ian Kimber. (1995). Retrospective appraisal of the relationship between skin irritancy and contact sensitization potential. Journal of Toxicology and Environmental Health. 46(2). 149–154. 14 indexed citations
12.
Auton, T.R.. (1994). Calculation of Benchmark Doses from Teratology Data. Regulatory Toxicology and Pharmacology. 19(2). 152–167. 16 indexed citations
13.
Auton, T.R., David R. Westhead, B.H. Woollen, R. C. Scott, & Martin F. Wilks. (1994). A Physiologically Based Mathematical Model of Dermal Absorption in Man. Human & Experimental Toxicology. 13(1). 51–60. 15 indexed citations
14.
Hilton, Jennifer, et al.. (1994). Vehicle Effects on in Vitro Percutaneous Absorption Through Rat and Human Skin. Pharmaceutical Research. 11(10). 1396–1400. 47 indexed citations
15.
Auton, T.R.. (1993). Concentration-flux relations for a multicellular biological membrane with metabolism. Mathematical Biosciences. 115(1). 103–117. 7 indexed citations
16.
Auton, T.R., J.D. Ramsey, & B.H. Woollen. (1993). Modelling Dermal Pharmacokinetics Using in vitro Data Part I. Fluazifop-butyl in the Rat. Human & Experimental Toxicology. 12(3). 199–206. 5 indexed citations
17.
Auton, T.R., Jacob D. Ramsey, & B.H. Woollen. (1993). Modelling Dermal Pharmacokinetics Using in vitro Data. Part II. Fluazifop-butyl in Man. Human & Experimental Toxicology. 12(3). 207–213. 10 indexed citations
18.
Ramsey, Jacob D., et al.. (1992). Pharmacokinetics of Fluazifop-butyl in Human Volunteers II: Dermal Dosing. Human & Experimental Toxicology. 11(4). 247–254. 15 indexed citations
19.
Wilson, H K, et al.. (1990). Human inhalation pharmacokinetics of 1,1,2-trichloro-1,2,2-trifluoroethane (FC113). International Archives of Occupational and Environmental Health. 62(1). 73–78. 6 indexed citations
20.
Auton, T.R.. (1987). The lift force on a spherical body in a rotational flow. Journal of Fluid Mechanics. 183. 199–218. 422 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026